Smelly Topamax recall causes another headache for J&J
This article was originally published in Scrip
Executive Summary
In a saga that never seems to end for Johnson & Johnson, the company is again recalling one of its drugs, but this time it involves a prescription drug, its antiseizure and migraine headache drug Topamax (topiramate).